Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models
Giovanni Nardo, Maria Chiara Trolese, Massimo Tortarolo, et al.
Brain Pathology (2016) Vol. 26, Iss. 2, pp. 237-247
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells
Caterina Peggion, Valeria Scalcon, Maria Lina Massimino, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 614-614
Open Access | Times Cited: 57
Cell therapy in ALS: An update on preclinical and clinical studies
Francesca Sironi, Fabiola De Marchi, Letizia Mazzini, et al.
Brain Research Bulletin (2023) Vol. 194, pp. 64-81
Open Access | Times Cited: 24
Animal models of amyotrophic lateral sclerosis: A comparison of model validity
C. Shaw, J. Morrice, CherylY Gregory-Evans
Neural Regeneration Research (2018) Vol. 13, Iss. 12, pp. 2050-2050
Open Access | Times Cited: 82
Immune response in peripheral axons delays disease progression in SOD1G93A mice
Giovanni Nardo, Maria Chiara Trolese, Giuseppe de Vito, et al.
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Expression of p16 and p21 in the frontal association cortex of ALS/MND brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease
Irina Vázquez-Villaseñor, Claire J. Garwood, Paul R. Heath, et al.
Neuropathology and Applied Neurobiology (2019) Vol. 46, Iss. 2, pp. 171-185
Open Access | Times Cited: 60
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions
Aidan J. Murphy, Steve D. Wilton, May T. Aung-Htut, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 7
Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice
Giovanni Nardo, Maria Chiara Trolese, Mattia Verderio, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 55
RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue
Antonio Vallarola, Francesca Sironi, Massimo Tortarolo, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 44
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
Tommaso Iannitti, Joseph M. Scarrott, Shibi Likhite, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 12, pp. 75-88
Open Access | Times Cited: 40
Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis
Irene Zubiri, Vittoria Lombardi, Michael Bremang, et al.
Molecular Neurodegeneration (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
Cassandra Margotta, Paola Fabbrizio, Marco Ceccanti, et al.
Inflammation and Regeneration (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 12
Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 37
Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
Marco Ceccanti, Valeria Pozzilli, Chiara Cambieri, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1174-1174
Open Access | Times Cited: 31
Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice
Maria Chiara Trolese, Carlotta Scarpa, Valentina Melfi, et al.
Molecular Therapy (2022) Vol. 30, Iss. 8, pp. 2760-2784
Open Access | Times Cited: 18
Drug Combination to Slow Down the Progression of Amyotrophic Lateral Sclerosis
Myriam Torres-Rico, Borja Marín-Rodríguez, Miriam Samira Arasmou-Idrovo, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis
Melania Filareti, Silvia Luotti, Laura Pasetto, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 31
Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis
Stefanie Schreiber, Frank Schreiber, Cornelia Garz, et al.
Muscle & Nerve (2019) Vol. 59, Iss. 5, pp. 567-576
Closed Access | Times Cited: 27
Associations of cardiovascular risk factors and lifestyle behaviors with neurodegenerative disease: a Mendelian randomization study
Liangyu Huang, Ya‐Nan Ou, Yuxiang Yang, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice
Elena Niccolai, Leandro Di Gloria, Maria Chiara Trolese, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention
Michael Benatar, Janice Robertson, Peter M. Andersen
The Lancet Neurology (2024) Vol. 24, Iss. 1, pp. 77-86
Closed Access | Times Cited: 3
Inhibition of Salt‐Inducible Kinase 2 Protects Motor Neurons From Degeneration in ALS by Activating Autophagic Flux and Enhancing mTORC1 Activity
Weiwei Liang, Chun‐Ting Zhang, Di Wang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression
Lauren Marie Landoni, Jacob R. Myles, Tyler L. Wells, et al.
Behavioural Brain Research (2019) Vol. 369, pp. 111914-111914
Closed Access | Times Cited: 24
CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
Maria Chiara Trolese, Alessandro Mariani, Mineko Terao, et al.
EBioMedicine (2020) Vol. 62, pp. 103097-103097
Open Access | Times Cited: 23
The p97‐Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis
Andrea David Re Cecconi, Mara Barone, Simona Gaspari, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 4, pp. 2225-2241
Open Access | Times Cited: 14
T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis
Julia P. Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top